sukh pharma ltd

Live YoungMicroDeclining

sukh pharma ltd Company Information

Share SUKH PHARMA LTD

Company Number

12439578

Shareholders

tarandeep rana

Group Structure

View All

Industry

General medical practice activities

 

Registered Address

4 sitwell walk, leicester, leicestershire, LE5 5TZ

Website

-

sukh pharma ltd Estimated Valuation

£48.5k

Pomanda estimates the enterprise value of SUKH PHARMA LTD at £48.5k based on a Turnover of £114.7k and 0.42x industry multiple (adjusted for size and gross margin).

sukh pharma ltd Estimated Valuation

£0

Pomanda estimates the enterprise value of SUKH PHARMA LTD at £0 based on an EBITDA of £-20.6k and a 3.14x industry multiple (adjusted for size and gross margin).

sukh pharma ltd Estimated Valuation

£114.1k

Pomanda estimates the enterprise value of SUKH PHARMA LTD at £114.1k based on Net Assets of £45.4k and 2.51x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Sukh Pharma Ltd Overview

Sukh Pharma Ltd is a live company located in leicestershire, LE5 5TZ with a Companies House number of 12439578. It operates in the general medical practice activities sector, SIC Code 86210. Founded in February 2020, it's largest shareholder is tarandeep rana with a 100% stake. Sukh Pharma Ltd is a young, micro sized company, Pomanda has estimated its turnover at £114.7k with declining growth in recent years.

View Sample
View Sample
View Sample

Sukh Pharma Ltd Health Check

Pomanda's financial health check has awarded Sukh Pharma Ltd a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating2.5out of 5
positive_score

2 Strong

positive_score

1 Regular

positive_score

7 Weak

size

Size

annual sales of £114.7k, make it smaller than the average company (£1.2m)

£114.7k - Sukh Pharma Ltd

£1.2m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -4%, show it is growing at a slower rate (10.8%)

-4% - Sukh Pharma Ltd

10.8% - Industry AVG

production

Production

with a gross margin of 23.9%, this company has a higher cost of product (46%)

23.9% - Sukh Pharma Ltd

46% - Industry AVG

profitability

Profitability

an operating margin of -18% make it less profitable than the average company (5.5%)

-18% - Sukh Pharma Ltd

5.5% - Industry AVG

employees

Employees

with 1 employees, this is below the industry average (16)

1 - Sukh Pharma Ltd

16 - Industry AVG

paystructure

Pay Structure

on an average salary of £35.2k, the company has an equivalent pay structure (£35.2k)

£35.2k - Sukh Pharma Ltd

£35.2k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £114.7k, this is more efficient (£91.2k)

£114.7k - Sukh Pharma Ltd

£91.2k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 140 days, this is later than average (36 days)

140 days - Sukh Pharma Ltd

36 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 12 days, this is quicker than average (26 days)

12 days - Sukh Pharma Ltd

26 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Sukh Pharma Ltd

- - Industry AVG

cashbalance

Cash Balance

There is insufficient data available for this Key Performance Indicator!

- - Sukh Pharma Ltd

- - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 8.1%, this is a lower level of debt than the average (53.7%)

8.1% - Sukh Pharma Ltd

53.7% - Industry AVG

SUKH PHARMA LTD financials

EXPORTms excel logo

Sukh Pharma Ltd's latest turnover from February 2024 is estimated at £114.7 thousand and the company has net assets of £45.4 thousand. According to their latest financial statements, Sukh Pharma Ltd has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Feb 2024Feb 2023Feb 2022Feb 2021
Turnover114,652163,663198,423130,188
Other Income Or Grants
Cost Of Sales87,238126,448151,40397,857
Gross Profit27,41437,21547,02032,331
Admin Expenses48,0325,16122,4297,445
Operating Profit-20,61832,05424,59124,886
Interest Payable
Interest Receivable
Pre-Tax Profit-20,61832,05424,59124,886
Tax-6,090-4,672-4,728
Profit After Tax-20,61825,96419,91920,158
Dividends Paid
Retained Profit-20,61825,96419,91920,158
Employee Costs35,22633,34331,85131,064
Number Of Employees1111
EBITDA*-20,61832,05424,59124,886

* Earnings Before Interest, Tax, Depreciation and Amortisation

Feb 2024Feb 2023Feb 2022Feb 2021
Tangible Assets3,9342,8031,580997
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets3,9342,8031,580997
Stock & work in progress
Trade Debtors44,20575,29376,96946,552
Group Debtors
Misc Debtors1,309
Cash
misc current assets
total current assets45,51475,29376,96946,552
total assets49,44878,09678,54947,549
Bank overdraft
Bank loan
Trade Creditors 2,99211,14237,55926,478
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
total current liabilities2,99211,14237,55926,478
loans
hp & lease commitments
Accruals and Deferred Income1,033913913913
other liabilities
provisions
total long term liabilities1,033913913913
total liabilities4,02512,05538,47227,391
net assets45,42366,04140,07720,158
total shareholders funds45,42366,04140,07720,158
Feb 2024Feb 2023Feb 2022Feb 2021
Operating Activities
Operating Profit-20,61832,05424,59124,886
Depreciation
Amortisation
Tax-6,090-4,672-4,728
Stock
Debtors-29,779-1,67630,41746,552
Creditors-8,150-26,41711,08126,478
Accruals and Deferred Income120913
Deferred Taxes & Provisions
Cash flow from operations1,1311,223583997
Investing Activities
capital expenditure-1,131-1,223-583-997
Change in Investments
cash flow from investments-1,131-1,223-583-997
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
interest
cash flow from financing
cash and cash equivalents
cash
overdraft
change in cash

sukh pharma ltd Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for sukh pharma ltd. Get real-time insights into sukh pharma ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Sukh Pharma Ltd Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for sukh pharma ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in LE5 area or any other competitors across 12 key performance metrics.

sukh pharma ltd Ownership

SUKH PHARMA LTD group structure

Sukh Pharma Ltd has no subsidiary companies.

Ultimate parent company

SUKH PHARMA LTD

12439578

SUKH PHARMA LTD Shareholders

tarandeep rana 100%

sukh pharma ltd directors

Sukh Pharma Ltd currently has 1 director, Mr Tarandeep Rana serving since Feb 2020.

officercountryagestartendrole
Mr Tarandeep RanaUnited Kingdom28 years Feb 2020- Director

P&L

February 2024

turnover

114.7k

-30%

operating profit

-20.6k

0%

gross margin

24%

+5.15%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

February 2024

net assets

45.4k

-0.31%

total assets

49.4k

-0.37%

cash

0

0%

net assets

Total assets minus all liabilities

Similar Companies

Similar companies unavailable for this selection

sukh pharma ltd company details

company number

12439578

Type

Private limited with Share Capital

industry

86210 - General medical practice activities

incorporation date

February 2020

age

5

incorporated

UK

ultimate parent company

None

accounts

Micro-Entity Accounts

last accounts submitted

February 2024

previous names

N/A

accountant

-

auditor

-

address

4 sitwell walk, leicester, leicestershire, LE5 5TZ

Bank

-

Legal Advisor

-

sukh pharma ltd Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to sukh pharma ltd.

sukh pharma ltd Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for SUKH PHARMA LTD. This can take several minutes, an email will notify you when this has completed.

sukh pharma ltd Companies House Filings - See Documents

datedescriptionview/download